Ophthalmology Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study. September 10, 2024
Ophthalmology Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis. May 6, 2022